A

Accelerate@Babraham

Europe, Cambridgeshire, United Kingdom, Cambridge

Description

Accelerate@Babraham is the incubation programme of the Babraham Research Campus.

Investor Profile

Accelerate@Babraham has made 6 investments, with 0 in the past 12 months and 83% as lead.

Stage Focus

  • Grant (83%)
  • Pre Seed (17%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Machine Learning
  • Medical
  • Biopharma
  • Genetics
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Alternative Protein
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Accelerate@Babraham frequently co-invest with?

Deep Science Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Avonmore Developments
Europe, England, United Kingdom, London
Co-Investments: 1
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 1
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton
Co-Investments: 1
KQ Labs
Europe, England, United Kingdom, London
Co-Investments: 1
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
Illumina
North America, California, United States, San Diego
Co-Investments: 1
R42 Group
North America, California, United States, Stanford
Co-Investments: 1

What are some of recent deals done by Accelerate@Babraham?

Concr

London, England, United Kingdom

Astrophysics technology for precision therapy through accurate modelling of biology

BiopharmaBiotechnologyMachine Learning
Pre SeedApr 1, 2021
Amount Raised: $691,491
Qkine

Cambridge, Cambridgeshire, United Kingdom

Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications

Alternative ProteinBiotechnologyLife Science
GrantJul 12, 2018
Amount Raised: $26,357
Oppilotech

London, England, United Kingdom

Developing the next generation of antibiotics with novel mechanisms of action.

BiotechnologyGeneticsHealth CareLife ScienceMedicalPharmaceutical
GrantJul 12, 2018
Amount Raised: $26,357
Antiverse

Cardiff, Cardiff, United Kingdom

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Artificial Intelligence (AI)BiotechnologyHealth CareLife ScienceMachine Learning
GrantJul 12, 2018
Amount Raised: $26,357
Kalium Health

Cambridge, Cambridgeshire, United Kingdom

Patient-centric kidney disease management

Health Care
GrantJul 12, 2018
Amount Raised: $30,000
VisusNano

Stevenage, Herefordshire, United Kingdom

Revolutionising Treatment for Cataracts

BiotechnologyHealth CareMedical
GrantJul 12, 2018
Amount Raised: $26,357